Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Cash & Current Investments (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Cash & Current Investments was $3.31 billion in Q2 2026, up 15.8% from $2.86 billion a year earlier and up 9.9% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Alnylam Pharmaceuticals came in at $2.91 billion, up 8.2% from FY2024.

  • Cash & Current Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $2.69 billion in FY2024 (+10.7%), $2.43 billion in FY2023 (+12.1%), $2.17 billion in FY2022 (-8.6%) and $2.37 billion in FY2021 (+29.4%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments in data going back to Q2 2009.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 10.5% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2022 (growth of 33.6%); the worst was Q4 2022 (a decline of 8.6%).
  • Per Business Quant data, ALNY's Cash & Current Investments in the three quarters before Q2 2026 was $3.01 billion (Q1 2026), $2.91 billion (Q4 2025) and $2.72 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 20.76 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 6.57 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 9.92 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 4.97 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 3.18 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 11.70 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 7.85 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 3.31 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.31 Bn
Mar 31, 2026 3.01 Bn
Dec 31, 2025 2.91 Bn
Sep 30, 2025 2.72 Bn
Jun 30, 2025 2.86 Bn
Mar 31, 2025 2.63 Bn
Dec 31, 2024 2.69 Bn
Sep 30, 2024 2.77 Bn
Jun 30, 2024 2.61 Bn
Mar 31, 2024 2.36 Bn
Dec 31, 2023 2.43 Bn
Sep 30, 2023 2.40 Bn
Jun 30, 2023 2.03 Bn
Mar 31, 2023 2.04 Bn
Dec 31, 2022 2.17 Bn
Sep 30, 2022 2.24 Bn
Jun 30, 2022 2.08 Bn
Mar 31, 2022 2.21 Bn
Dec 31, 2021 2.37 Bn
Sep 30, 2021 2.26 Bn
API Access

Alnylam Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALNY&period=max&api_key=YOUR_API_KEY